A €135m Biomedical Sciences Institute by Trinity College Dublin (TCD) is believed to deliver top-notch health research with added advantages of boosting education and aiding economic recovery. The landmark will encapsulate TCD’s school of medicine, biochemistry, immunology, pharmacy, pharmaceutical science, chemistry and engineering.

The TCD Dean of research Dr. David Lloyd claimed that the TCD had already led the world class research in biomedical sciences, from developing the nicotine patch to identifying new genes for childhood eczema and increasing understanding of major diseases like Alzheimer's, cancer and arthritis.

“The impact that this is going to have in the future on the lives of millions of people is incredible”, said Enda Kenny, during the official opening of institute. “Trinity scientists were already delivering important findings, including the discovery of genes associated with childhood eczema and new ways to control malaria”.

In addition to this, he also stressed on the need of such developments and said that the country was struggling with economic challenges and frequent funding research could play a role to provide new employment opportunities as well as companies.

Further, European commissioner for research innovation and science, Maire Geoghegan-Quinn said that research and innovation are the top priorities of European agenda.